Elsevier

Clinical Oncology

Volume 17, Issue 6, September 2005, Pages 478-484
Clinical Oncology

Overview
Aloe Vera for Preventing Radiation-induced Skin Reactions: A Systematic Literature Review

https://doi.org/10.1016/j.clon.2005.04.013Get rights and content

Abstract

Aim

To systematically review and critically appraise the evidence for effectiveness of Aloe vera gel for radiation-induced skin reactions.

Materials and methods

Major biomedical databases and specialist complementary and alternative medicine databases were searched. Additionally, efforts were made to identify unpublished and ongoing research. Relevant research was systematically categorised by study type and appraised according to study design. Clinical commentaries were obtained for each study included in the review.

Results

One earlier systematic review on Aloe vera for a variety of conditions was located. Five published randomised-controlled trials (RCTs) were found, along with two additional RCTs that are not published. No non-RCTs, uncontrolled studies or qualitative studies were found.

Conclusions

There is no evidence from clinical trials to suggest that topical Aloe vera is effective in preventing or minimising radiation-induced skin reactions in cancer patients. Further methodologically rigorous, sufficiently powered research studies should be conducted to evaluate the effectiveness of currently used and novel therapies for the prevention, minimisation and management of radiation-induced skin reactions.

Introduction

Radiation-induced skin reactions remain a common adverse effect of radiotherapy treatment for cancer, despite the introduction of sophisticated skin-sparing techniques. Concomitant chemotherapy and radiotherapy can further increase the risk of an adverse reaction [1]. Estimations of the extent of skin reactions experienced by women undergoing radiotherapy for breast cancer range from 87% to 96% 2, 3.

Reactions vary from mild erythema to moist desquamation [2]. The reported incidence of moist desquamation is, however, relatively low (10–15%) 1, 3. Severity of skin reaction depends on a number of factors, including radiation fractionation, total dose, anatomic treatment area, radiation energy and individual patient differences, such as obesity and smoking habits 4, 5, 6. Archambeau et al. [7] report that skin damage has a dose–response relationship, starting at 20–25 Gy. In practice, this means that skin reactions occur around the second to third week of radical radiotherapy, reaching a peak towards the end of treatment 8, 9. Skin reactions can cause pain and discomfort, and may be dose-limiting 10, 11. General skin care advice, such as washing and avoidance of friction and trauma, are recommended [1]. The patient experience of symptom distress associated with radiation treatment is, however, an area that has been poorly researched [1].

The management of skin reactions across the UK has previously been reported to be inconsistent 12, 13, 14. Guidelines produced by NHS Quality Improvement Scotland [15] advise that only skin-care products advocated by the radiotherapy treatment centre should be applied. In 1995, a survey reported that 50% of the Radiation Therapy Oncology Group (RTOG) institutions used Aloe vera gel as a routine treatment [2]. However, Aloe vera does not feature in current practice guidelines [15]. Wells and MacBride [1] suggest that creams with active and moisturising ingredients may prevent the onset and severity of erythema, but indicate that more research is necessary (p. 156).

According to Murray and Pizzorno [16], more than 300 species of Aloe vera plants exist, the most popular medical variety being Aloe vera. The nomenclature of Aloe vera is confusing because the plant is known by a variety of names, most notably Aloe babadensis and Aloe vulgari. Furthermore, the geographical origin of the plant is unclear. Historical records indicate that it may have originated from Egypt or the Middle East, but Aloe has been introduced throughout the tropics and warmer regions of the world. Aloe vera gel should not be confused with aloe juice or latex, which is obtained from the same plant. Aloe gel is a clear jelly-like substance that is obtained from the thin-walled sticky cells of the inner portion of the leaf. Aloe latex (or juice) is obtained from the cells beneath the plant's skin, and contains laxative anthraquinones [17].

Aloe vera is commonly used to treat a number of skin complaints, such as dry skin and irritant contact dermatitis [18], and for the healing of burns [19]. The use of Aloe vera in the treatment of radiation-induced dermatitis has been reported in the literature as early as 1935 [20]. Aloe vera gel has also been assessed as a treatment for radiation-induced mucositis [21]; Klein and Penneys [22] suggest that studies and case reports provide support for the use of Aloe vera in the treatment of radiation ulcers and stasis ulcers in humans. Furthermore, Aloe vera as a tincture has also been researched as a treatment for cancer progression [23].

Section snippets

Aim

To review systematically the currently available evidence on the effectiveness of Aloe vera for the prevention and minimisation of radiation-induced skin reactions in cancer patients.

Materials and Methods

A comprehensive search was conducted of major biomedical databases, including MEDLINE, EMBASE, CINAHL, PsycINFO, CENTRAL (Cochrane Central Register of Controlled Trials), The Cochrane Database of Systematic Reviews and DARE (Database of Abstracts of Reviews of Effects). Specialist complementary and alternative medicine (CAM) databases including AMED and CISCOM were also searched. Searches were undertaken in August 2004. Owing to the different indexing procedures used by these databases, search

Search Terms

The aim of the review was to focus on studies conducted in cancer patients, rather than focus on a particular type of cancer. We therefore developed a generic cancer search strategy based on the Cochrane Cancer Network (a Cochrane Field) strategy rather than one of those relating to a specific type of cancer. This generic strategy was adapted, based on the results of initial searches, and further terms were included to ensure comprehensiveness. For example, terms relating to radiotherapy were

Selection and Appraisal

Relevant research was systematically categorised by study type. No language limitations were imposed at the search and filtering stage. Animal research and basic laboratory-based research were not included in the categorisation process.

Inclusion Criteria

All research studies where Aloe vera gel was applied as a specific intervention for the prevention and/or treatment of radiation-induced skin reactions in cancer patients. Studies had to include a clinical evaluation of skin reaction outcome.

Data Collection and Analysis

All relevant studies were appraised, and their methodological quality assessed. Relevant information was extracted independently by two reviewers using a standardised data extraction and critical appraisal form (DECA form). Differences were resolved by discussion and, if necessary, a third reviewer was involved. Where required, the advice of a statistician was sought. The DECA form was based on criteria recommended by the Centre for Reviews and Dissemination [25]. These criteria specifically

Clinical Commentaries

One experienced herbal practitioner and one clinical oncologist were asked to comment on each study, focusing on the appropriateness of the intervention, clinical relevance and practical issues according to guidelines developed specifically for the project. Summaries of these commentaries are provided in the table of studies (Table 1).

Systematic Reviews

Vogler and Ernst [26] conducted a systematic review on Aloe vera for a range of conditions, and reported two clinical trials for the treatment of radiotherapy skin reactions. A number of clinical trials have been published since this review.

Trials

Five published RCTs were located 20, 27, 28, 29, 30. Two RCTs were undertaken but not published. All randomised trials located are presented in Table 1, together with comments on their methodology and clinical relevance. Trials are further discussed in

Randomised-Controlled Trials (RCTs)

Bosley et al. [27] report the results of 45 paediatric cancer patients undergoing radiotherapy (primarily for non-Hodgkins lymphoma of the thorax) with a minimum 23.4 Gy. Both 1% anionic phospholipid-based cream and an Aloe vera-based gel were applied adjacently in the area of the field of radiation by a nurse. Participants thus acted as their own controls, and nurses were not blinded. Scores from patient-reported skin comfort variables and researcher-recorded dermatologic assessments using

Discussion

Methodological limitations in the literature reported in this review include a lack of reporting of the methods of randomisation, blinding, sampling and recruitment, handling of missing values or losses to follow-up. However, differences in appearance, smell or texture between Aloe vera gel and the other products used may cause difficulties in ensuring adequate blinding. Co-interventions and compliance were not always reported. In addition, timing and frequency of application, as well as data

Conclusion

The trials reviewed here confirm established risk factors for radiation skin reaction, namely radiation dose, skin complexion, weight and bra cup size, age, concomitant chemotherapy and smoking [1]. They also highlight differences between patient and clinician rating of severity of skin reactions, a point useful for future research into treatment effects.

There is no evidence based on current research to suggest that Aloe vera gel is effective for the prevention and/or treatment of

Acknowledgements

Anelia Boshnakova, Electronic Information Officer, RCCM for advice and support with search strategies and searches; The Project Advisory Group and Specialist Advisory Group (cancer) for the NHS Priorities Project for advice and support to the project; The NHS Priorities Project is funded by the Department of Health. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Department of Health.

References (34)

  • D. Porock et al.

    Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings

    Eur J Cancer Care (Engl)

    (1999)
  • A. Blackmar

    Radiation-induced skin alterations

    Medsurg Nurs

    (1997)
  • D. Porock et al.

    Predicting the severity of radiation skin reactions in women with breast cancer

    Oncol Nurs Forum

    (1998)
  • E. Sitton

    Early and late radiation-induced skin alterations. Part 1: mechanisms of skin changes

    Oncol Nurs Forum

    (1992)
  • T. Arimoto et al.

    Acute skin reactions observed in fractioned proton irradiation

    Radiat Med

    (1989)
  • C. Ratcliff

    Impaired skin integrity related to radiation therapy

    J Enterostomal Ther

    (1990)
  • A.J. Munro et al.

    Distress associated with radiotherapy for malignant disease; a quantitative analysis based on patient perceptions

    Br J Cancer

    (1989)
  • Cited by (129)

    View all citing articles on Scopus
    View full text